Publication
Road to COP29: Our insights
The 28th Conference of the Parties on Climate Change (COP28) took place on November 30 - December 12 in Dubai.
Author:
Canada | Publication | November 29, 2021
The Government of Alberta’s Bill 47: Ensuring Safety and Cutting Red Tape Act, 2020 introduced changes to the Occupational Health and Safety Act (OHS Act) that will come into effect December 1, 2021. In this update, we break down the key features of the amendments.
The circumstances leading to the right to refuse work are reduced in scope and limited to situations where serious and immediate threats to the health and safety of a worker are present. Previously, the right to refuse work was available for any dangerous condition that posed a danger to the worker, with no protection against other workers who may be endangered as a result of the refusal to work.
The new provisions regarding disciplinary actions provide OHS officers more authority to dismiss frivolous complaints and ensure complaints are addressed in a timely manner. Where a disciplinary action was taken against a worker, the onus of establishing that such action was taken for legitimate reasons remains on the employer.
Lastly, employers will now have more flexibility in training workers, implementing health and safety programs, and establishing health and safety committees that are tailored to specific workplace needs.
Publication
The 28th Conference of the Parties on Climate Change (COP28) took place on November 30 - December 12 in Dubai.
Publication
While country risk cannot be avoided in cross-border transactions entirely, it can be effectively mitigated through careful transaction structuring and tailored contractual protections.
Publication
Miranda Cole, Julien Haverals and Emma Clarke of our Brussels/ London offices are the authors of a chapter on procedural issues in merger control that has been published in the third edition of the Global Competition Review’s The Guide to Life Sciences. This covers a number of significant procedural developments that have affected merger review of life sciences transactions.
Subscribe and stay up to date with the latest legal news, information and events . . .
© Norton Rose Fulbright LLP 2023